Skip to main content
SpringerLink
Log in
Book cover

Radiation Oncology pp 283–298Cite as

Bladder Cancer

  • Chapter

  • 1975 Accesses

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

Abstract

Bladder cancer is one of the most common malignancies of the urinary tract and is a disease that ranges from localized disease treated with cystoscopy and transurethral tumor resection only to metastatic disease that requires systemic therapy. Although the majority of patients present with superficial disease, approximately one third of patients with bladder cancer will have muscle invasion, and localized invasive disease often requires multidisciplinary management, particularly if bladder preservation is to be attempted.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abol-Enein H, Kava BR, Carmack AJ (2007) Nonurothelial cancer of the bladder. Urology 69(1 Suppl):93–104

    Article  PubMed  Google Scholar 

  • Advanced Bladder Cancer Meta-Analysis Collaboration (2003) Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis. Lancet 361:1927–1934

    Article  CAS  Google Scholar 

  • Advanced Bladder Cancer (ABC) Meta-Analysis Collaboration (2005) Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data. Eur Urol 48:189–199

    Article  Google Scholar 

  • Anderström C, Johansson S, Nilsson S et al. (1983) A prospective randomized study of preoperative irradiation with cystectomy or cystectomy alone for invasive bladder carcinoma. Eur Urol 9:142–147

    PubMed  Google Scholar 

  • Anderström C, Johansson SL, von Schultz L (1983) Primary adenocarcinoma of the urinary bladder. A clinicopathologic and prognostic study. Cancer 52:1273–1280

    Article  PubMed  Google Scholar 

  • Bessell EM, Taylor J, Moloney AJ et al. (1993) Regression of transitional cell carcinoma of the bladder with radiotherapy: progression-free control in the bladder at 5 years. Radiother Oncol 29:344–346

    Article  PubMed  CAS  Google Scholar 

  • Bjerre BD, Johansen C, Steven K (1995) Health-related quality of life after cystectomy: bladder substitution compared with ileal conduit diversion. A questionnaire survey. Br J Urol 75:200–205

    Article  PubMed  CAS  Google Scholar 

  • Blank LE, Koedooder K, van Os R et al. (2007) Results of bladder-conserving treatment, consisting of brachytherapy combined with limited surgery and external beam radiotherapy, for patients with solitary T1-T3 bladder tumors less than 5 cm in diameter. Int J Radiat Oncol Biol Phys 69:454–458

    PubMed  Google Scholar 

  • Bono AV, Benvenuti C, Reali L et al. (1989) Adjuvant chemotherapy in advanced bladder cancer. Italian Uro-Oncologic Cooperative Group. Prog Clin Biol Res 303:533–540

    PubMed  CAS  Google Scholar 

  • Caffo O, Fellin G, Graffer U et al. (1996) Assessment of quality of life after cystectomy or conservative therapy for patients with infiltrating bladder carcinoma. A survey by a self-administered questionnaire. Cancer 78:1089–1097

    Article  PubMed  CAS  Google Scholar 

  • Chakravarti A, Winter K, Wu CL et al. (2005) Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: a report from the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 62:309–317

    PubMed  CAS  Google Scholar 

  • Chung PW, Bristow RG, Milosevic MF et al. (2007) Long-term outcome of radiation-based conservation therapy for invasive bladder cancer. Urol Oncol 25:303–309

    PubMed  Google Scholar 

  • Cole CJ, Pollack A, Zagars GK et al. (1995) Local control of muscle-invasive bladder cancer: preoperative radiotherapy and cystectomy versus cystectomy alone. Int J Radiat Oncol Biol Phys 32:331–340

    Article  PubMed  CAS  Google Scholar 

  • Coppin CM, Gospodarowicz MK, James K et al. (1996) Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 14:2901–2907

    PubMed  CAS  Google Scholar 

  • Daehlin L, Haukaas S, Maartmann-Moe H et al. (1999) Survival after radical treatment for transitional cell carcinoma of the bladder. Eur J Surg Oncol 25:66–70

    Article  PubMed  CAS  Google Scholar 

  • Dandekar NP, Dalal AV, Tongaonkar HB et al. (1997) Adenocarcinoma of bladder. Eur J Surg Oncol 23:157–160

    Article  PubMed  CAS  Google Scholar 

  • Dotan ZA, Kavanagh K, Yossepowitch O et al. (2007) Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival. J Urol 178:2308–2312

    Article  PubMed  Google Scholar 

  • Duncan W, Quilty PM (1986) The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy. Radiother Oncol 7:299–310

    Article  PubMed  CAS  Google Scholar 

  • Felix AS, Soliman AS, Khaled H et al. (2008) The changing patterns of bladder cancer in Egypt over the past 26 years. Cancer Causes Control 19:421–429

    Article  PubMed  Google Scholar 

  • Fossa SD, Aass N, Ous S et al. (1996) Survival after curative treatment of muscle-invasive bladder cancer. Acta Oncol 35[Suppl 8]:59–65

    Article  PubMed  Google Scholar 

  • Freiha F, Reese J, Torti FM (1996) A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. J Urol 155:495–499

    Article  PubMed  CAS  Google Scholar 

  • Ghoneim MA, Ashamallah AK, Awaad HK et al. (1985) Randomized trial of cystectomy with or without preoperative radiotherapy for carcinoma of the bilharzial bladder. J Urol 134:266–268

    PubMed  CAS  Google Scholar 

  • Goodman GB, Hislop TG, Elwood JM et al. (1981) Conservation of bladder function in patients with invasive bladder cancer treated by definitive irradiation and selective cystectomy. Int J Radiat Oncol Biol Phys 7:569–573

    PubMed  CAS  Google Scholar 

  • Goffinet DR, Schneider MJ, Glatstein EJ et al. (1975) Bladder cancer: results of radiation therapy in 384 patients. Radiology 117:149–153

    PubMed  CAS  Google Scholar 

  • Gospodarowicz MK, Hawkins NV, Rawlings GA et al. (1989) Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis. J Urol 142:1448–1453

    PubMed  CAS  Google Scholar 

  • Grossman HB, Natale RB, Tangen CM et al. (2003) Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349:859–866

    Article  PubMed  CAS  Google Scholar 

  • Hagan MP, Winter KA, Kaufman DS et al. (2003) RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy. Int J Radiat Oncol Biol Phys 57:665–672

    PubMed  Google Scholar 

  • Hall R (2002) On behalf of the International Collaboration of Trialists of the MRC Advanced Bladder Cancer Group: updated results of a randomised controlled trial of neoadjuvant cisplatin (C), methotrexate (M) and vinblastine (V) chemotherapy for muscle-invasive bladder cancer. Proc Am Soc Clin Oncol 21:178(abstract)

    Google Scholar 

  • Hardt J, Filipas D, Hohenfellner R et al. (2000) Quality of life in patients with bladder carcinoma after cystectomy: first results of a prospective study. Qual Life Res 9:1–12

    Article  PubMed  CAS  Google Scholar 

  • Haresh KP, Julka PK, Sharma DN et al. (2007) A prospective study evaluating surgery and chemo radiation in muscle invasive bladder cancer. J Cancer Res Ther 3:81–85

    Article  PubMed  CAS  Google Scholar 

  • Harker WG, Meyers FJ, Freiha FS et al. (1985) Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study. J Clin Oncol 3:1463–1470

    PubMed  CAS  Google Scholar 

  • Hart S, Skinner EC, Meyerowitz BE et al. (1999) Quality of life after radical cystectomy for bladder cancer in patients with an ileal conduit, cutaneous or urethral Kock pouch. J Urol 162:77–81

    Article  PubMed  CAS  Google Scholar 

  • Hautmann RE, Gschwend JE, de Petriconi RC et al. (2006) Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era. J Urol 176:486–492

    Article  PubMed  Google Scholar 

  • Heicappell R, Muller-Mattheis V, Reinhardt M et al. (1999) Staging of pelvic lymph nodes in neoplasms of the bladder and prostate by positron emission tomography with 2-[(18)F]-2-deoxy-D-glucose. Eur Urol 36:582–587

    Article  PubMed  CAS  Google Scholar 

  • Henningsohn L, Wijkström H, Dickman PW et al. (2002) Distressful symptoms after radical radiotherapy for urinary bladder cancer. Radiother Oncol 62:215–225

    Article  PubMed  Google Scholar 

  • Holzbeierlein JM, Lopez-Corona E, Bochner BH (2004) Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection. J Urol 172:878–881

    Article  PubMed  Google Scholar 

  • Housset M, Maulard C, Chretien Y et al. (1993) Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study. J Clin Oncol 11:2150–2157

    PubMed  CAS  Google Scholar 

  • Huncharek M, Muscat J, Geschwind JF et al. (1998) Planned preoperative radiation therapy in muscle invasive bladder cancer; results of a meta-analysis. Anticancer Res 18:1931–1934

    PubMed  CAS  Google Scholar 

  • Jenkins BJ, Caulfield MJ, Fowler CG et al. (1988) Reappraisal of the role of radical radiotherapy and salvage cystectomy in the treatment of invasive (T2/T3) bladder cancer. Br J Urol 62:343–346

    Article  PubMed  CAS  Google Scholar 

  • Johnson DE, Schoenwald MB, Ayala AG et al. (1976) Squamous cell carcinoma of the bladder. J Urol 115:542–544

    PubMed  CAS  Google Scholar 

  • Kassouf W, Swanson D, Kamat AM et al. (2006) Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the MD Anderson Cancer Center experience. J Urol 175:2058–2062

    Article  PubMed  Google Scholar 

  • Kaufman D, Raghavan D, Carducci M et al. (2000a) Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer. J Clin Oncol 18:1921–1927

    PubMed  CAS  Google Scholar 

  • Kaufman DS, Winter KA, Shipley WU et al. (2000b) The initial results in muscle-invading bladder cancer of RTOG 95-06: phase I/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-fluorouracil followed by selective bladder preservation or cystectomy depending on the initial response. Oncologist 5:471–476

    Article  PubMed  CAS  Google Scholar 

  • Kaufman DS, Winter KA, Shipley WU et al. (2005) Muscle-invading bladder cancer, RTOG Protocol 99-06: Initial report of a phase I/II trial of selective bladder-conservation employing TURBT, accelerated irradiation sensitized with cisplatin and paclitaxel followed by adjuvant cisplatin and gemcitabine chemotherapy. J Clin Oncol 2005 ASCO Annual Meeting Proceedings 23[1 Suppl]:4506

    Google Scholar 

  • Kosuda S, Kison PV, Greenough R et al. (1997) Preliminary assessment of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with bladder cancer. Eur J Nucl Med 24:615–620

    PubMed  CAS  Google Scholar 

  • Lagwinski N, Thomas A, Stephenson AJ et al. (2007) Squamous cell carcinoma of the bladder: a clinicopathologic analysis of 45 cases. Am J Surg Pathol 31:1777–1787

    Article  PubMed  Google Scholar 

  • Lotan Y, Roehrborn CG (2003) Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses. Urology 61:109–118

    Article  PubMed  Google Scholar 

  • Madersbacher S, Hochreiter W, Burkhard F et a. (2003) Radical cystectomy for bladder cancer today-a homogeneous series without neoadjuvant therapy. J Clin Oncol 21:690–696

    Article  PubMed  Google Scholar 

  • Mameghan H, Fisher R, Mameghan J et al. (1995) Analysis of failure following definitive radiotherapy for invasive transitional cell carcinoma of the bladder. Int J Radiat Oncol Biol Phys 31:247–254

    PubMed  CAS  Google Scholar 

  • Mallampati GK, Siegelman ES (2004) MR imaging of the bladder. Magn Reson Imaging Clin N Am 12:545–555

    Article  PubMed  Google Scholar 

  • Malmström PU, Rintala E, Wahlqvist R et al. (1996) Five-year follow-up of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group. J Urol 155:1903–1906

    Article  PubMed  Google Scholar 

  • Månsson A, Johnson G, Månsson W (1988) Quality of life after cystectomy. Comparison between patients with conduit and those with continent caecal reservoir urinary diversion. Br J Urol 62:240–245

    Article  PubMed  Google Scholar 

  • MRC/ EORTC (1999) Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists. Lancet 354:533–540

    Article  Google Scholar 

  • National Comprehensive Cancer Network (2008) Clinical practice guidelines in oncology: Bladder cancer. Available at http://www.nccn.org Accessed on 24 February 2008

    Google Scholar 

  • Nocks BN, Heney NM, Daly JJ (1983) Primary adenocarcinoma of urinary bladder. Urology 21:26–29

    Article  PubMed  CAS  Google Scholar 

  • Parsons JT, Million RR (1989) Role of planned preoperative irradiation in the management of clinical stage B2-C (T3) bladder carcinoma in the 1980s. Semin Surg Oncol 5:255–265

    Article  PubMed  CAS  Google Scholar 

  • Pawinski A, Sylvester R, Kurth KH et al. (1996) A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer. European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder Cancer. J Urol 156:1934–1940

    Article  PubMed  CAS  Google Scholar 

  • Quilty PM, Duncan W (1986) Radiotherapy for squamous carcinoma of the urinary bladder. Int J Radiat Oncol Biol Phys 12:861–865

    PubMed  CAS  Google Scholar 

  • Raleigh ED, Berry M, Montie JE (1995) A comparison of adjustments to urinary diversions: a pilot study. J Wound Ostomy Continence Nurs 22:58–63

    PubMed  CAS  Google Scholar 

  • Richie JP, Waisman J, Skinner DG et al. (1976) Squamous carcinoma of the bladder: treatment by radical cystectomy. J Urol 115:670–672

    PubMed  CAS  Google Scholar 

  • Robinson P, Collins CD, Ryder WD et al. (2000) Relationship of MRI and clinical staging to outcome in invasive bladder cancer treated by radiotherapy. Clin Radiol 55:301–306

    Article  PubMed  CAS  Google Scholar 

  • Rödel C, Grabenbauer GG, Kühn R et al. (2002) Combinedmodality treatment and selective organ preservation in invasive bladder cancer: long-term results. J Clin Oncol 20:3061–3071

    Article  PubMed  Google Scholar 

  • Rundle JS, Hart AJ, McGeorge A et al. (1982) Squamous cell carcinoma of bladder. A review of 114 patients. Br J Urol 54:522–526

    Article  PubMed  CAS  Google Scholar 

  • Sengeløv L, Kamby C, Lund B et al. (1998) Docetaxel and cisplatin in metastatic urothelial cancer: a phase II study. J Clin Oncol 16:3392–3397

    PubMed  Google Scholar 

  • Serretta V, Pomara G, Piazza F et al. (2000) Pure squamous cell carcinoma of the bladder in western countries. Report on 19 consecutive cases. Eur Urol 37:85–89

    Article  PubMed  CAS  Google Scholar 

  • Sherif A, Rintala E, Mestad O et al. (2002) Neoadjuvant cisplatin-methotrexate chemotherapy for invasive bladder cancer-Nordic cystectomy trial 2. Scand J Urol Nephrol 36:419–425

    Article  PubMed  CAS  Google Scholar 

  • Shipley WU, Rose MA, Perrone TL et al. (1985) Full-dose irradiation for patients with invasive bladder carcinoma: clinical and histological factors prognostic of improved survival. J Urol 134:679–683

    PubMed  CAS  Google Scholar 

  • Shipley WU, Prout GR Jr, Einstein AB et al. (1987) Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery. JAMA 258:931–935

    Article  PubMed  CAS  Google Scholar 

  • Shipley WU, Winter KA, Kaufman DS et al. (1998) Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03. J Clin Oncol 16:3576–3583

    PubMed  CAS  Google Scholar 

  • Shipley WU, Kaufman DS, Zehr E et al. (2002) Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer. Urology 60:62–67

    Article  PubMed  CAS  Google Scholar 

  • Siefker-Radtke AO, Dinney CP, Abrahams NA et al. (2004) Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the MD Anderson cancer experience. J Urol 172:481–484

    Article  PubMed  Google Scholar 

  • Skinner DG, Daniels JR, Russell CA et al. (1991) The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol 145:459–464

    PubMed  CAS  Google Scholar 

  • Smith JA Jr, Crawford ED, Paradelo JC et al. (1997) Treatment of advanced bladder cancer with combined preoperative irradiation and radical cystectomy versus radical cystectomy alone: a phase III intergroup study. J Urol 157:805–807

    Article  PubMed  Google Scholar 

  • Stein JP, Lieskovsky G, Cote R et al. (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19:666–675

    PubMed  CAS  Google Scholar 

  • Sternberg CN, Yagoda A, Scher HI et al. (1989) Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse. Cancer 64:2448–2458

    Article  PubMed  CAS  Google Scholar 

  • Stöckle M, Meyenburg W, Wellek S et al. (1995) Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience. J Urol 153:47–52

    Article  PubMed  Google Scholar 

  • Studer UE, Bacchi M, Biedermann C et al. (1994) Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer: results of a prospective randomized trial. J Urol 152:81–84

    PubMed  CAS  Google Scholar 

  • Sved P, Gomez P, Manoharan M et al. (2004) Small cell carcinoma of the bladder. BJU Int 94:12–17

    Article  PubMed  Google Scholar 

  • Swanson DA, Liles A, Zagars GK (1990) Preoperative irradiation and radical cystectomy for stages T2 and T3 squamous cell carcinoma of the bladder. J Urol 143:37–40

    PubMed  CAS  Google Scholar 

  • Sylvester RJ, van der Meijden AP, Witjes JA et al. (2005) Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials. J Urol 174:86–91

    Article  PubMed  CAS  Google Scholar 

  • Tekes A, Kamel I, Imam K et al. (2005) Dynamic MRI of bladder cancer: evaluation of staging accuracy. Am J Roentgenol 184:121–127

    Google Scholar 

  • Tester W, Porter A, Asbell S et al. (1993) Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12. Int J Radiat Oncol Biol Phys 25:783–790

    PubMed  CAS  Google Scholar 

  • Tester W, Caplan R, Heaney J et al. (1996) Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802. J Clin Oncol 14:119–126

    PubMed  CAS  Google Scholar 

  • Tonoli S, Bertoni F, De Stefani A et al. (2006) Radical radiotherapy for bladder cancer: retrospective analysis of a series of 459 patients treated in an Italian institution. Clin Oncol (R Coll Radiol) 18:52–59

    CAS  Google Scholar 

  • Von der Maase H, Hansen SW, Roberts JT et al. (2001) Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol 19:1229–1231

    Google Scholar 

  • Wasco MJ, Daignault S, Zhang Y et al. (2007) Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection. Urology 70:69–74

    Article  PubMed  Google Scholar 

  • Zaghloul MS, Nouh A, Nazmy M et al. (2006) Long-term results of primary adenocarcinoma of the urinary bladder: a report on 192 patients. Urol Oncol 24:13–20

    PubMed  Google Scholar 

  • Zietman AL, Sacco D, Skowronski U et al. (2003) Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors. J Urol 170:1772–1776

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Maimonides Cancer Center, 6300 Eighth Avenue, Brooklyn, NY, 11020, USA

    James S. Butler MD

Authors
  1. James S. Butler MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology National University Cancer Institute of Singapore National University Health System, National University of Singapore, 5 Lower Kent Ridge Road, Singapore, 119074, Singapore

    Jiade J. Lu MD, MBA (Associate Professor and Consultant and Distinguished Clinical Professor) (Associate Professor and Consultant and Distinguished Clinical Professor)

  2. Department of Radiation Oncology, Cancer Hospital of Fudan University, 270 Dong An Road, Shanghai, 200232, P.R. China

    Jiade J. Lu MD, MBA (Associate Professor and Consultant and Distinguished Clinical Professor) (Associate Professor and Consultant and Distinguished Clinical Professor)

  3. College of Medicine, Drexel University, Broad & Vine Sts., Mail Stop 200, Philadelphia, PA, 19102-1192, USA

    Luther W. Brady MD (Hylda Cohn/American Cancer Society Professor of Clinical Oncology, and Professor, Department of Radiation Oncology Distinguished University Professor) (Hylda Cohn/American Cancer Society Professor of Clinical Oncology, and Professor, Department of Radiation Oncology Distinguished University Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Butler, J.S. (2008). Bladder Cancer. In: Lu, J.J., Brady, L.W. (eds) Radiation Oncology. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-77385-6_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-77385-6_19

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-77384-9

  • Online ISBN: 978-3-540-77385-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation